Science-based and practice-based innovativeness and performance of substance abuse treatment facilities

Health Care Management Review

Volumn 39, Issue 1, 2014, Pages 66-74

  Nayar, Preethy ^a   Yu, Fang ^a   Apenteng, Bettye ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Multinomial logistic regression; Organizational innovativeness; Organizational performance; Practice based innovation; Science based innovation

Indexed keywords

ADDICTION; ARTICLE; CROSS-SECTIONAL STUDY; DRUG DEPENDENCE TREATMENT; EVIDENCE BASED PRACTICE; HUMAN; ORGANIZATION; ORGANIZATION AND MANAGEMENT; STANDARD; UNITED STATES;

CROSS-SECTIONAL STUDIES; EVIDENCE-BASED PRACTICE; HUMANS; ORGANIZATIONAL INNOVATION; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84890565949     PISSN: 03616274     EISSN: 15505030     Source Type: Journal    
DOI: 10.1097/HMR.0b013e318282663f     Document Type: Article

References (33)

1. Adelman, R., McGee, P., Power, R., Hanson, C. (2005). Reducing adolescent clients' anger in a residential substance abuse treatment facility. Joint Commission Journal on Quality & Patient Safety, 31(6), 325-337.
2. Andrews, C., Dingcai, C., Marsh, J., & Shin, H. (2011). The impact of comprehensive services in substance abuse treatment for women with a history of intimate partner violence. Violence Against Women, 17(5), 550-567.
3. Ashley, O., Marsden, M., & Brady, T. (2003). Effectiveness of substance abuse treatment programming for women:Areview. The American Journal of Drug and Alcohol Abuse, 29(1), 19-53.
4. Babbor, T. F., & Kadden, R. F. (2005). Screening and interventions for alcohol and drug problems in medical settings: What works? Journal of Trauma, 59(Suppl 3), S80-S87, discussion S94-S100.
5. Bien, T. H., Miller, W. R., & Tonigan, J. S. (1993). Brief interventions for alcohol problems: A review. Addiction, 88(3), 315-335.
6. Brannigan, R., Schackman, B. R., Falco, M., & Millman, R. B. (2004). The quality of highly regarded adolescent substance abuse treatment programs. Archives of Pediatric & Adolescent Medicine, 158904-909.
7. Bride, B., Abraham, A., & Roman, P. (2011). Organizational factors associated with the use of contingency management in publicly funded substance abuse treatment centers. Journal of Substance Abuse Treatment, 40(1), 87-94.
8. Delany, P., Shields, J., & Roberts, D. (2009). Program and client characteristics as predictors of the availability of social support services in community-based substance abuse treatment programs. The Journal of Behavioral Health Services & Research, 36(4), 450-464.
9. Donabedian, A. (1988). The quality of care. How can it be assessed? JAMA: The Journal of the American Medical Association, 260(12), 1743-1748.
10. Ducharme, L., Mello, H., Roman, P., Knudsen, H., & Johnson, J. (2007). Service delivery in substance abuse treatment: Reexamining "comprehensive" care. The Journal of Behavioral Health Services & Research, 34(2), 121-136.
11. Ducharme, L. J., Knudsen, H. K., & Roman, P. M. (2006).Trends in the adoption of medications for alcohol dependence. Journal of Clinical Psychopharmacology, 26(Supp1), S13-S19.
12. Fields, D., & Roman, P. (2010). Total quality management and performance in substance abuse treatment centers. Health Services Research, 45(6 Pt 1), 1630-1649.
13. Fuller, B. E., Rieckmann, T., Nunes, E. V., Miller, M., Arfken, C., Edmundson, E., & McCarty, D. (2007). Organizational readiness for change and opinions toward treatment innovations. Journal of Substance Abuse Treatment, 33(2), 183-192.
14. Graham, A. (2002). Review: Brief interventions reduce drinking in patients not seeking treatment. Evidence Based Mental Health, 5(4), 116-127.
15. Haug, N., Shopshire, M., Tajima, B., Gruber, V., & Guydish, J. (2008). Adoption of evidence-based practices among substance abuse treatment providers. Journal of Drug Education, 38(2), 181-192.
16. Hovmand, P. S., & Gillespie, D. F. (2010). Implementation of evidence-based practice and organizational performance. Journal of Behavioral Health Services and Research; the Journal of Behavioral Health Services, 37(1), 79-94.
17. Institute of Medicine. (2000). To err is human: Building a safer health system. Washington, DC: National Academy Press.
18. Knudsen, H., Ducharme, L., & Roman, P. (2007). The adoption of medications in substance abuse treatment: Associations with organizational characteristics and technology clusters. Drug And Alcohol Dependence, 87(2-3), 164-174.
19. Knudsen, H., Roman, P., & Oser, B. (2010). Facilitating factors and barriers to the use of medications in publicly funded addiction treatment organizations. Journal of Addiction Medicine, 4(2), 99-107.
20. Koch, A., Arfken, C., & Schuster, C. (2006). Characteristics of U.S. substance abuse treatment facilities adopting buprenorphine in its initial stage of availability. Drug and Alcohol Dependence, 83(3), 274-278.
21. Massatti, R., Sweeney, H., Panzano, P., & Roth, D. (2008). The de-adoption of innovative mental health practices (IMHP): Why organizations choose not to sustain an IMHP. Administration and Policy in Mental Health, 35(1-2), 50-65.
22. McCaul, M., & Petry, N. (2003). The role of psychosocial treatments in pharmacotherapy for alcoholism. The American Journal on Addictions/American Academy of Psychiatrists in Alcoholism and Addictions, 12(Suppl 1), S41-S52.
23. McConnell, K. J., Hoffman, K. A., Quanbeck, A., & McCarty, D. (2009). Management practices in substance abuse treatment programs. Journal of Substance Abuse Treatment, 37(1), 79-89.
24. National Institute on Drug Abuse. (1999). Principles of drug addiction treatment (NIH publication 99-4180). Washington, DC: National Institutes of Health.
25. Oser, C., Knudsen, H., Staton-Tindall, M., & Leukefeld, C. (2009). The adoption of wraparound services among substance abuse treatment organizations serving criminal offenders: The role of a women-specific program. Drug and Alcohol Dependence, 103(Suppl. 1), S82-S90.
26. Oser, C., & Roman, P. (2007). Organizational-level predictors of adoption across time: Naltrexone in private substance-use disorders treatment centers. Journal of Studies on Alcohol and Drugs, 68(6), 852-861.
27. Panzano, P., & Roth, D. (2006). The decision to adopt evidence-based and other innovative mental health practices: Risky business? Psychiatric Services (Washington, DC), 57(8), 1153-1161.
28. Roman, P., Abraham, A., Rothrauff, T., & Knudsen, H. (2010).A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse Treatment, 38(Suppl 1), S44-S52.
29. Salge, T., & Vera, A. (2009). Hospital innovativeness and organizational performance: Evidence from English public acute care. Health Care Management Review, 34(1), 54-67.
30. Saxon, A., & McCarty, D. (2005). Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs. Pharmacology & Therapeutics, 108(1), 119-128.
31. Stitzer, M., & Vandrey, R. (2008). Contingency management: Utility in the treatment of drug abuse disorders. Clinical Pharmacology and Therapeutics, 83(4), 644-647.
32. U.S. Department of Health and Human Services. (2009). Substance Abuse and Mental Health Services Administration, Office of Applied Studies, National Survey of Substance Abuse Treatment Services (N-SSATS), United States [Computer file]. ICPSR28781-v1. Ann Arbor, MI: Inter-University Consortium for Political and Social Research [distributor], 2010-07-20. doi:10.3886/ICPSR28781
33. Weiss, R. D., & Kueppenbender, K. D. (2006). Combining psychosocial treatment with pharmacotherapy for alcohol dependence. Journal of Clinical Psychopharmacology, 26(Suppl 1), S37-S42.